Retatrutide Half-Life: 6 Days and Why That Matters

Retatrutide's half-life of approximately 6 days is one of the key pharmacokinetic properties that makes this investigational triple-agonist weight loss drug practical for patients. Published Phase 2 data (Jastreboff et al., NEJM 2023) showed that once-weekly dosing produced an average of 24.2% body weight loss at the highest dose — and the 6-day half-life is what enables that convenient dosing schedule to work. But the half-life affects much more than just how often you inject.

What Is a Drug Half-Life?

A drug's half-life is the time it takes for the concentration of the drug in your blood to drop to 50% of its peak level. For retatrutide, that is approximately 6 days (144 hours). After 6 days, half the drug remains active. After another 6 days (12 days total), one quarter remains. After about 30 days (5 half-lives), the drug is essentially eliminated from your system.

Half-life determines how frequently a drug needs to be dosed to maintain effective blood levels. Too short a half-life means the drug wears off quickly, requiring daily or multiple-daily dosing. Too long means the drug accumulates excessively or takes too long to clear if side effects occur.

How 6 Days Enables Weekly Dosing

Retatrutide's 6-day half-life is in the pharmacological sweet spot for once-weekly injection:

At steady state (after several weeks of weekly dosing), the drug accumulates slightly, meaning the trough levels before each dose are higher than they would be after a single injection. This accumulation is predictable and is accounted for in the dose escalation protocol.

Half-Life Comparison with Other GLP-1 Drugs

All three weekly injectables — semaglutide, tirzepatide, and retatrutide — have half-lives in the 5-7 day range. This consistency means that patients experienced with semaglutide or tirzepatide will find the dosing rhythm of retatrutide familiar.

Half-Life and Side Effect Management

Understanding the half-life helps patients manage side effects more effectively:

• Peak side effects: GI side effects (nausea, diarrhea) are typically strongest 24-72 hours after injection when drug levels are highest. Planning your injection day accordingly (e.g., Friday evening for a quieter weekend) can help.
• Persistent effects: Because the drug stays active for days, side effects can last longer than with short-acting medications. This is normal and does not mean the drug has accumulated excessively.
• Clearance time: If you experience intolerable side effects and stop the medication, it takes approximately 24-30 days (4-5 half-lives) for the drug to substantially clear from your system. Side effects will gradually diminish during this period.
• Dose escalation logic: The gradual dose escalation protocol gives your body time to adjust at each level. With a 6-day half-life, steady state at each dose is reached in approximately 4-5 weeks (4-5 half-lives).

Reaching Steady State

Steady state is when the amount of drug entering your system (weekly injection) equals the amount being eliminated. For retatrutide, steady state is achieved after approximately 4-5 half-lives of consistent dosing at a given dose level, which translates to about 4-5 weeks.

This has practical implications:

• First few weeks: Drug levels are building. Side effects may increase as levels rise but often stabilize once steady state is reached.
• After dose increases: Each time you escalate to a higher dose, it takes another 4-5 weeks to reach the new steady state. This is why dose escalation occurs at 4-week intervals.
• Full effect: The full weight loss effect of a given dose may not be apparent until steady state is reached. Patience during the titration phase is important.

What If You Miss a Dose?

The 6-day half-life provides some buffer for missed doses. Because meaningful drug levels persist for several days past the scheduled injection, a dose that is a day or two late will not result in a complete loss of therapeutic effect. However, consistently timing your injections is recommended for optimal results.

General guidance for similar weekly GLP-1 medications suggests: if you miss a dose, take it as soon as you remember as long as there are at least 3 days until your next scheduled dose. If fewer than 3 days remain, skip the missed dose and return to your regular schedule.

Available Now: Weekly GLP-1 Injections

The same convenient once-weekly dosing is already available with current GLP-1 medications through TRIMI:

• Compounded semaglutide: 7-day half-life, once-weekly injection, $99/month
• Compounded tirzepatide: 5-day half-life, once-weekly injection, $125/month

Learn more about how TRIMI works and how to get started with proven weight loss medications today.